Carcinoma, Hepatocellular: all 3,249 studies
Page 9 of 33. Open to participants first (974), then studies with results posted, then the rest; newest registration first within each.
- Nocardia Rubra Cell Wall Skeleton (N-CWS) Plus HAIC, Lenvatinib and Tislelizumab in Treating Patients With Advanced HCCRecruitingNCT05533892Phase 1
- Ultrasound-guided Continuous Low Serratus Anterior Plane Block in Hepatocellular Carcinoma SurgeryRecruitingNCT05531864Not applicable
- Evaluation of the Interest to Combine a CD4 Th1-inducer Cancer Vaccine Derived From Telomerase and Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular CarcinomaRecruitingNCT05528952Phase 2
- Sintilimab Combined With Lenvatinib Versus HAIC for Perioperative Treatment of Resectable Primary Hepatocellular CarcinomaRecruitingNCT05519410Phase 2
- Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular CarcinomaRecruitingNCT05516628Phase 2
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsRecruitingNCT05503797Phase 2
- Relevance of Sarcopenia in Advanced Liver DiseaseRecruitingNCT05502198
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic CancersRecruitingNCT05497531Not applicable
- Novel Biomarker Assay for Biomarker Assay for HCC DetectionNot yet recruitingNCT05494853
- A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative ResectionRecruitingNCT05489289Phase 3
- SBRT With Atezo/Bev for HCCRecruitingNCT05488522Phase 1
- Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIRecruitingNCT05486572Not applicable
- Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCCRecruitingNCT05484908Not applicable
- HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority StudyRecruitingNCT05476432Phase 3
- Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver TransplantationRecruitingNCT05475613Phase 2
- Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor PatientsRecruitingNCT05468359Phase 1/2
- Antiviral Therapy for Patients With Liver Cancer After SurgeryRecruitingNCT05466565
- Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic TherapiesEnrolling by invitationNCT05448222
- Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular CarcinomaRecruitingNCT05444478Not applicable
- Study of SHR-8068 Combined With Adebrelimab and Bevacizumab in the Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT05444088Phase 1/2
- TARGETed Therapy Drug MONITOring in DIGestive OncologyRecruitingNCT05443087Not applicable
- A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC PatientsEnrolling by invitationNCT05441475Phase 2
- Durvalumab and Tremelimumab in Resectable HCCRecruitingNCT05440864Phase 2
- A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaRecruitingNCT05440708Phase 1/2
- CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical ResectionRecruitingNCT05433467Not applicable
- Validation of SMS Protocol for HCC Screening in High-risk PatientsEnrolling by invitationNCT05429190
- mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCCRecruitingNCT05412589Phase 2
- A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular CarcinomaRecruitingNCT05409482
- the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular CarcinomaRecruitingNCT05408221Phase 2/3
- A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative ResectionRecruitingNCT05407519Phase 2
- Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNARecruitingNCT05375370Not applicable
- Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular CarcinomaRecruitingNCT05366829Phase 2
- Study of Microwave Spherical Ablation and Traditional Microwave Ablation in Single Hepatocellular Carcinoma ≤5cmRecruitingNCT05361538Not applicable
- A Head-to-head Comparison of MRI, CT, 18F-FDGal and 18F-choline in Patients With Hepatocellular CarcinomaRecruitingNCT05359939Not applicable
- NewishT Cell Therapy for HCC With High Risk of Recurrence After Radical ResectionRecruitingNCT05352646Phase 1
- Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Excision of Primary Liver TumorsRecruitingNCT05331911Phase 4
- Study Of B7H3 CAR-T Cells in Treating Advanced Liver CancerRecruitingNCT05323201Phase 1/2
- Study of ADI-PEG 20 Versus Placebo in Subjects With High Arginine Level and Unresectable Hepatocellular CarcinomaRecruitingNCT05317819Phase 3
- A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC ClassificationRecruitingNCT05313282Phase 3
- Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular CarcinomaRecruitingNCT05304481Phase 2
- Impact of Hepatitis B Immunoglobulins in Patients With Chronic Hepatitis B on Hepatocellular Carcinoma - a Proof of Concept StudyNot yet recruitingNCT05293158Not applicable
- Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.Not yet recruitingNCT05286320Phase 1/2
- Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant CandidatesRecruitingNCT05276037
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
- Glypican-3 as a Prognostic Factor in Patients With Hepatocellular Carcinoma Treated by ImmunotherapyRecruitingNCT05263830
- DEB-TACE+HAIC vs. HAIC for Large HCCRecruitingNCT05263219Phase 3
- Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep LearningRecruitingNCT05257694
- CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular CarcinomaRecruitingNCT05257590Phase 2
- TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCCRecruitingNCT05250843Phase 2/3
- Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTTRecruitingNCT05225116Phase 1
- An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic CholangiocarcinomaRecruitingNCT05223816Phase 2
- Adjuvant Immune Checkpoint Inhibitors in Postoperative Hepatocellular CarcinomaRecruitingNCT05221398
- A Study of PF-08046054/SGN-PDL1V in Advanced Solid TumorsRecruitingNCT05208762Phase 1
- A National Phase II Study of Proton Therapy in Hepatocellular CarcinomaRecruitingNCT05203120Not applicable
- Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 CirrhosisRecruitingNCT05201404Phase 3
- Multi-analyte Blood Test Clinical TrialRecruitingNCT05199259
- Study of HBV-TCR T Cells (LioCyx-M) as Monotherapy or as Combination With Lenvatinib for HBV-related HCCNot yet recruitingNCT05195294Phase 2
- Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)RecruitingNCT05185739Phase 2
- Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan CriteriaEnrolling by invitationNCT05185505Phase 4
- Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid TumorsRecruitingNCT05176483Phase 1
- Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Atezolizumab Plus BevacizumabRecruitingNCT05173298
- Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver CancerRecruitingNCT05168163Phase 2
- Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.Not yet recruitingNCT05162898Not applicable
- A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular CarcinomaRecruitingNCT05155189Phase 1
- Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis GuidelinesRecruitingNCT05143619
- Evaluation of Resection Techniques for Pancreatic TumorsRecruitingNCT05128890
- Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACENot yet recruitingNCT05125094
- Individualized Dosimetry for Holmium-166-radioembolization in Patients With Unresectable Hepatocellular CarcinomaRecruitingNCT05114148Not applicable
- PVE/PVL Combined With DEB-TACE in the Treatment of Patients With Large and Unresectable Liver CancerRecruitingNCT05103007Not applicable
- FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.RecruitingNCT05095714Not applicable
- Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxRecruitingNCT05092373Phase 1
- Safety and Efficacy of Degradable Microsphere in Transcatheter Arterial Chemoembolization for Hepatocellular CarcinomaRecruitingNCT05072041Not applicable
- Hepatectomy Combined With Camrelizumab and Apatinib in CNLC Stage IIIb HCCRecruitingNCT05062837Phase 2/3
- Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular CarcinomaRecruitingNCT05057845Phase 2
- High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver MalignanciesRecruitingNCT05053555Not applicable
- Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular CarcinomaRecruitingNCT05048017Phase 2
- GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular CarcinomaRecruitingNCT05047510Not applicable
- Hyperbaric Oxygen Therapy Combined Camrelizumab in Patients With Advanced/Metastatic Hepatocellular CarcinomaRecruitingNCT05031949Phase 1
- Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid TumorsRecruitingNCT05024214Phase 1/2
- GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor MalignanciesRecruitingNCT05003895Phase 1
- Observational Study of Factors Predicting Therapeutic Effects and Clinical Prognosis After HAIC for Locally Advanced HCCRecruitingNCT05002452
- Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open HepatectomyRecruitingNCT04982653Phase 2
- TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTTRecruitingNCT04967495Not applicable
- Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular CarcinomaRecruitingNCT04965454Phase 2
- Intratumor CpG-ODN Injection Boosters Immune Killing Against in Situ Tumor Antigen Release for Advanced Solid TumorsRecruitingNCT04952272Phase 1
- Camrelizumab in Patients With Unresectable Hepatocellular CarcinomaNot yet recruitingNCT04947956
- Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma PatientsRecruitingNCT04933435Not applicable
- Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRCRecruitingNCT04912765Phase 2
- GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCCRecruitingNCT04864054Phase 1/2
- Laparoscopic Versus Open Major Hepatectomy for HCC Hepatectomy for Hepatocellular CarcinomaRecruitingNCT04852211Not applicable
- Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsRecruitingNCT04851119Phase 1/2
- Liver Transplantation for Unresectable GIST Liver MetastasesNot yet recruitingNCT04825470Not applicable
- Hepatic Intra-Arterial Administration of Ipilimumab in Combination With Intra-venous Nivolumab for Advanced Hepatocellular CarcinomaRecruitingNCT04823403Phase 1
- The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular CarcinomaRecruitingNCT04803994Phase 3
- Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid TumorsRecruitingNCT04803318Phase 2
- The Role Of Circulating Tumor Cells As Markers Of Advanced Disease And Prognosis In HCCRecruitingNCT04800497
- Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular CarcinomaRecruitingNCT04797884Phase 2/3
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition SyndromeRecruitingNCT04792463
- Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)RecruitingNCT04777942Not applicable
- Intra-tumor Injection of Drug-eluting Microspheres With Multiple DrugsRecruitingNCT04770207Phase 2